Aggressive breast cancers may be sensitive to drugs clogging their waste disposal
Key points
- In a new paper in Cancer Cell, a team led by Judy Lieberman, PhD, of Boston Children's Hospital's Program in Cellular and Molecular Medicine reports "triple-negative" breast cancers may be vulnerable to drugs that attack the proteasome.
- These cancers, which lack the three major therapeutic markers for breast cancer - the estrogen, progesterone and HER2 receptors - are very aggressive and difficult to treat.
- By selectively turning genes off throughout the genomes of triple-negative tumor cells in vitro, Lieberman's team found that these cells absolutely require active proteasomes in order to live.
- These data suggest that triple-negative breast cancers may respond to treatment with drugs similar to bortezomib (Velcade®), a proteasome inhibitor that revolutionized the care of patients with the blood cancer multiple myeloma.
In a new paper in Cancer Cell, a team led by Judy Lieberman, PhD, of Boston Children's Hospital's Program in Cellular and Molecular Medicine reports "triple-negative" breast cancers may be vulnerable to drugs that attack the proteasome. This cellular structure acts as the cell's waste disposal, breaking down damaged or unneeded proteins.
These cancers, which lack the three major therapeutic markers for breast cancer - the estrogen, progesterone and HER2 receptors - are very aggressive and difficult to treat. They mostly affect younger women and have the worst prognosis of all breast cancers.
By selectively turning genes off throughout the genomes of triple-negative tumor cells in vitro, Lieberman's team found that these cells absolutely require active proteasomes in order to live. When turned off, the cells die.
These data suggest that triple-negative breast cancers may respond to treatment with drugs similar to bortezomib (Velcade®), a proteasome inhibitor that revolutionized the care of patients with the blood cancer multiple myeloma.
The study was supported by the Department of Defense Breast Cancer Research Program, the National Cancer Institute (grant number R01CA146445) and the Breast Cancer Research Foundation.
Boston Children's Hospital is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 1,100 scientists, including seven members of the National Academy of Sciences, 13 members of the Institute of Medicine and 14 members of the Howard Hughes Medical Institute comprise Boston Children's research community.
Founded as a 20-bed hospital for children, Boston Children's today is a 395-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Boston Children's is also the primary pediatric teaching affiliate of Harvard Medical School.
###
Boston Children's Hospital
cynthia.lepore@childrens.harvard.edu
617-919-3110
Boston Children's Hospital
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsMore younger women being diagnosed with aggressive breast cancer
There is a set back in the fight against breast cancer. More young women are getting advanced, deadly forms of cancer. When Sue Ellen Jimenez of Cranston found a lump back in 2011, she admits she didn't take it very…
28 February 2013
NewsResearchers discover promising prognostic marker for aggressive breast cancer
A team of researchers led by Goutham Narla, MD, PhD, at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, and collaborators at the Mount Sinai School of Medicine and…
24 January 2013
NewsStudy links milk-producing protein to aggressive breast cancer
The discovery that a protein which triggers milk production in women may also be responsible for making breast cancers aggressive could open up new opportunities for treatment of the most common and deadliest form of…
